Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

Prime minister visits Cornwall and Plymouth to promote the government's extra Growth Deal funding while deputy…

From next year air passengers will be able to do more transparent comparative shopping, comparing seat size, price,…

Areas including Hampshire, Norfolk, North East Lincolnshire, Southampton and Suffolk benefit from top-up for local…

Friendly, accessible, impartial information and data is a vital part of support for deafblind people and those…

Leighton Andrews rejects voluntary merger plans from Blaenau Gwent and Torfaen, Bridgend and the Vale of Glamorgan,…

Blackpool, St Ives, Scarborough, Brighton, Whitley Bay and Lincolnshire among seaside areas to get share of the…

Heathrow expansion will exacerbate rather than mitigate regional imbalances. By drawing more business into the…

Councils in England have increasing responsibility and influence over health and social care. They will need to…

The next InformationDaily.TV AnswerTime® recording 4 Feb and free to view on 8th unpicks the personal data…

Two neighbouring London boroughs plan to share services and staff with each hoping to save up to £10m a year…

2015 will be the year of the Internet of Things. Understanding data ownership is essential. The Midata scheme…

The world is changing! It has changed so much over the past two decades we can no longer expect a job for life,…